Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › TPP-1 formulations and methods for treating CLN2 disease

TPP-1 formulations and methods for treating CLN2 disease

US Patent 11229687 · Granted Jan 25, 2022

Estimated economic value: $99,644,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of c-type natriuretic peptide variants to treat osteoarthritis2025
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2024
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2024
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2023
Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of 2022
Targeted therapeutic lysosomal enzyme fusion proteins, associated formulations a2022
Use of C-type natriuretic peptide variants to treat osteoarthritis2021
Variants of C-type natriuretic peptide2020
TPP-1 formulations and methods for treating CLN2 disease2020
TPP-1 formulations and methods for treating CLN2 disease2020
TPP-1 formulations and methods for treating CLN2 disease2020
TPP-1 formulations and methods for treating CLN2 disease2020